JSP Pharmaceutical Manufacturing (Thailand) Public Balance Sheet Health
Financial Health criteria checks 5/6
JSP Pharmaceutical Manufacturing (Thailand) Public has a total shareholder equity of THB928.5M and total debt of THB160.8M, which brings its debt-to-equity ratio to 17.3%. Its total assets and total liabilities are THB1.4B and THB443.2M respectively. JSP Pharmaceutical Manufacturing (Thailand) Public's EBIT is THB965.3K making its interest coverage ratio 0.1. It has cash and short-term investments of THB34.3M.
Key information
17.3%
Debt to equity ratio
฿160.80m
Debt
Interest coverage ratio | 0.07x |
Cash | ฿34.30m |
Equity | ฿928.51m |
Total liabilities | ฿443.20m |
Total assets | ฿1.37b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: JSP-F's short term assets (THB274.7M) exceed its short term liabilities (THB209.5M).
Long Term Liabilities: JSP-F's short term assets (THB274.7M) exceed its long term liabilities (THB233.7M).
Debt to Equity History and Analysis
Debt Level: JSP-F's net debt to equity ratio (13.6%) is considered satisfactory.
Reducing Debt: JSP-F's debt to equity ratio has reduced from 181.9% to 17.3% over the past 5 years.
Debt Coverage: JSP-F's debt is well covered by operating cash flow (27.6%).
Interest Coverage: JSP-F's interest payments on its debt are not well covered by EBIT (0.1x coverage).